Immuron (IMRN) Short-term Investments (2023)

Immuron (IMRN) recorded quarterly Short-term Investments of $1.2 million in Q2 2023.

Immuron (IMRN) Short-term Investments (2023) Analysis & Trends

Immuron's Short-term Investments history runs 1 years deep, the most recent figure standing at $1.2 million for Q2 2023.

In Q2 2023, Short-term Investments changed N/A year-over-year to $1.2 million; the TTM figure through Jun 2023 stood at $1.2 million (changed N/A YoY), while the FY2023 annual figure was $1.2 million, changed N/A from the prior year.
Short-term Investments was $1.2 million for Q2 2023 at Immuron.
In the past five years, Short-term Investments ranged from a high of $1.2 million in Q2 2023 to a low of $1.2 million in Q2 2023.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Immuron	921.61 Mn	921.58 Mn	-

Historic Data

Download Data

Date	Value
Jun 30, 2023	1.23 Mn